Botulinum toxin physiology in focal hand and cranial dystonia
- PMID: 23202323
- PMCID: PMC3509715
- DOI: 10.3390/toxins4111404
Botulinum toxin physiology in focal hand and cranial dystonia
Abstract
The safety and efficacy of botulinum toxin for the treatment of focal hand and cranial dystonias are well-established. Studies of these adult-onset focal dystonias reveal both shared features, such as the dystonic phenotype of muscle hyperactivity and overflow muscle contraction and divergent features, such as task specificity in focal hand dystonia which is not a common feature of cranial dystonia. The physiologic effects of botulinum toxin in these 2 disorders also show both similarities and differences. This paper compares and contrasts the physiology of focal hand and cranial dystonias and of botulinum toxin in the management of these disorders.
Similar articles
-
Treatment of hyperfunctional lines of the face with botulinum toxin A.Dermatol Surg. 1998 Nov;24(11):1198-205. doi: 10.1111/j.1524-4725.1998.tb04098.x. Dermatol Surg. 1998. PMID: 9834739 Review.
-
[Treatment of focal dystonia with botulinum toxin A].Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Wien Klin Wochenschr. 2001. PMID: 15506045 Review. German.
-
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.Toxins (Basel). 2020 Apr 22;12(4):269. doi: 10.3390/toxins12040269. Toxins (Basel). 2020. PMID: 32331272 Free PMC article. Review.
-
[Focal dystonias and their treatment with dysport (botulinum toxin type A)].Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(5):81-9. Zh Nevrol Psikhiatr Im S S Korsakova. 2012. PMID: 22951787 Russian. No abstract available.
-
Botulinum toxin for treatment of jaw opening dystonia in Hallervorden-Spatz syndrome.Eur Neurol. 2001;45(4):287-8. doi: 10.1159/000052146. Eur Neurol. 2001. PMID: 11385272 No abstract available.
Cited by
-
Review: Botulinum Toxin for Treatment of Focal Limb Dystonia.Toxins (Basel). 2025 Mar 4;17(3):122. doi: 10.3390/toxins17030122. Toxins (Basel). 2025. PMID: 40137895 Free PMC article. Review.
-
Botulinum toxin and occupational therapy for Writer's cramp.Toxicon. 2019 Nov;169:12-17. doi: 10.1016/j.toxicon.2019.07.010. Epub 2019 Jul 24. Toxicon. 2019. PMID: 31351085 Free PMC article. Clinical Trial.
-
Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia.Toxins (Basel). 2022 Dec 1;14(12):844. doi: 10.3390/toxins14120844. Toxins (Basel). 2022. PMID: 36548741 Free PMC article. Review.
-
Central Effects of Botulinum Neurotoxin-Evidence from Human Studies.Toxins (Basel). 2019 Jan 6;11(1):21. doi: 10.3390/toxins11010021. Toxins (Basel). 2019. PMID: 30621330 Free PMC article. Review.
-
Muscle Selection for Focal Limb Dystonia.Toxins (Basel). 2017 Dec 29;10(1):20. doi: 10.3390/toxins10010020. Toxins (Basel). 2017. PMID: 29286305 Free PMC article. Review.
References
-
- Defazio G., Berardelli A., Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain. 2007;130:1183–1193. - PubMed
-
- Simpson D.M., Blitzer A., Brashear A., Comella C., Dubinsky R., Hallett M., Jankovic J., Karp B., Ludlow C.L., Miyasaki J.M., et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2008;70:1699–1706. doi: 10.1212/01.wnl.0000311389.26145.95. - DOI - PMC - PubMed
-
- Gowers W.R. A Manual of Diseases of the Nervous System. P. Blakiston’ Son & Co.; Philadelphia, PA, USA: 1888. pp. 1059–1078.
-
- Brandfonbrener A.G., Robson C. Review of 113 musicians with focal dystonia seen between 1985 and 2002 at a clinic for performing artists. Adv. Neurol. 2004;94:255–256. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical